A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
NCT06668805
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Noonan Syndrome
Interventions
DRUG:
Vosoritide Injection
Sponsor
BioMarin Pharmaceutical